WallStreetZen

NASDAQ: IRTC
iRhythm Technologies Inc Stock Forecast, Predictions & Price Target

Analyst price target for IRTC

Based on 6 analysts offering 12 month price targets for iRhythm Technologies Inc.
Min Forecast
$78.00+33.54%
Avg Forecast
$123.33+111.15%
Max Forecast
$288.00+393.07%

Should I buy or sell IRTC stock?

Based on 8 analysts offering ratings for iRhythm Technologies Inc.
Buy
Strong Buy
2 analysts 25%
Buy
0 analysts 0%
Hold
6 analysts 75%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

IRTC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Morgan Stanley
Bottom 50%
50
HoldMaintains$85.00+45.52%2021-06-03
Citigroup
Top 5%
96
HoldDowngrades$78.00+33.54%2021-06-02
Morgan Stanley
Top 6%
95
HoldDowngrades$94.00+60.93%2021-04-14
Truist Securities
Top 11%
90
Strong BuyMaintains$115.00+96.88%2021-04-13
BTIG
Top 10%
91
HoldDowngradesN/AN/A2021-04-13
Baird
Top 17%
84
HoldMaintains$80.00+36.96%2021-04-12
Colliers Securities
Bottom 12%
12
HoldDowngradesN/AN/A2021-02-26
Anonymous
Morgan Stanley
Strong BuyMaintains$288.00+393.07%2021-01-25

1 of 1

Forecast return on equity

Is IRTC forecast to generate an efficient return?
Company
-26.19%
Industry
18.2%
Market
1,975.19%
IRTC's Return on Equity is forecast to be low in 3 years (-26.19%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is IRTC forecast to generate an efficient return on assets?
Company
-16.54%
Industry
11.22%
Market
951.37%
IRTC is forecast to generate lower Return on Assets (-16.54%) than the US Medical Instruments & Supplies industry average (11.22%)
Forecast

IRTC earnings per share forecast

What is IRTC's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
-$3.66+79.41%
Avg 2 year Forecast
-$3.50+71.57%
Avg 3 year Forecast
-$2.73+33.82%

IRTC revenue forecast

What is IRTC's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$323.3M+5.55%
Avg 2 year Forecast
$343.4M+12.11%
Avg 3 year Forecast
$376.3M+22.83%
IRTC's revenue is forecast to grow at a rate of 6.43% per year, which is not exceptional
Forecast

IRTC revenue growth forecast

How is IRTC forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
6.43%
Industry
7.44%
Market
14.64%
IRTC's revenues are forecast to grow slower (6.43% per year) than the US Medical Instruments & Supplies industry average (7.44%)
Forecast
IRTC's revenues are forecast to grow slower (6.43% per year) than the US market average (14.64%)
Forecast

iRhythm Technologies Stock Forecast FAQ

Is iRhythm Technologies Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: IRTC) stock is to Buy IRTC stock.

Out of 8 analysts, 2 (25%) are recommending IRTC as a Strong Buy, 0 (0%) are recommending IRTC as a Buy, 6 (75%) are recommending IRTC as a Hold, 0 (0%) are recommending IRTC as a Sell, and 0 (0%) are recommending IRTC as a Strong Sell.

What is IRTC's earnings growth forecast for 2021-2023?

(NASDAQ: IRTC) iRhythm Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 30.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 22.98%.

iRhythm Technologies's earnings in 2021 is -$59,467,000.On average, 5 Wall Street analysts forecast IRTC's earnings for 2021 to be $-107,616,298, with the lowest IRTC earnings forecast at $-112,026,802, and the highest IRTC earnings forecast at $-103,793,861. On average, 6 Wall Street analysts forecast IRTC's earnings for 2022 to be $-102,911,760, with the lowest IRTC earnings forecast at $-133,785,288, and the highest IRTC earnings forecast at $-67,627,728.

In 2023, IRTC is forecast to generate $-80,271,173 in earnings, with the lowest earnings forecast at $-89,092,181 and the highest earnings forecast at $-71,156,131.

What is IRTC's revenue growth forecast for 2021-2023?

(NASDAQ: IRTC) iRhythm Technologies's forecast annual revenue growth rate of 6.43% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.64%.

iRhythm Technologies's revenue in 2021 is $306,342,000.On average, 5 Wall Street analysts forecast IRTC's revenue for 2021 to be $9,507,194,212, with the lowest IRTC revenue forecast at $9,479,643,264, and the highest IRTC revenue forecast at $9,530,511,077. On average, 6 Wall Street analysts forecast IRTC's revenue for 2022 to be $10,098,260,555, with the lowest IRTC revenue forecast at $7,997,713,920, and the highest IRTC revenue forecast at $10,936,697,365.

In 2023, IRTC is forecast to generate $11,063,984,511 in revenue, with the lowest revenue forecast at $9,585,495,360 and the highest revenue forecast at $12,332,357,251.

What is IRTC's forecast return on assets (ROA) for 2021-2023?

(NASDAQ: IRTC) forecast ROA is -16.54%, which is lower than the forecast US Medical Instruments & Supplies industry average of 11.22%.

What is IRTC's Price Target?

According to 6 Wall Street analysts that have issued a 1 year IRTC price target, the average IRTC price target is $123.33, with the highest IRTC stock price forecast at $288.00 and the lowest IRTC stock price forecast at $78.00.

On average, Wall Street analysts predict that iRhythm Technologies's share price could stay at $123.33 by Jun 3, 2022. The average iRhythm Technologies stock price prediction forecasts a potential downside of N/A from the current IRTC share price of $58.41.

What is IRTC's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: IRTC) iRhythm Technologies's current Earnings Per Share (EPS) is -$2.04. On average, analysts forecast that IRTC's EPS will be $-3.66 for 2021, with the lowest EPS forecast at $-3.81, and the highest EPS forecast at $-3.53. On average, analysts forecast that IRTC's EPS will be $-3.50 for 2022, with the lowest EPS forecast at $-4.55, and the highest EPS forecast at $-2.30. In 2023, IRTC's EPS is forecast to hit $-2.73 (min: $-3.03, max: $-2.42).

What is IRTC's forecast return on equity (ROE) for 2021-2023?

(NASDAQ: IRTC) forecast ROE is -26.19%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.